Clinical updates, including trial initiations, enrollment status and data readouts and publications: Blue Earth Diagnostics, Dariohealth, Medtronic, Reflexion Medical.

New hires and promotions in the med-tech industry, including: Greenbrook, Medtronic, Ultima Genomics.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Amylyx, Astrazeneca, Boehringer Ingelheim, Erasca, Gilead, Intercept, Janssen, Leo, Lianbio, Moderna, Molecure, Pfizer, Sarepta, Zealand.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adamis, Advancell, Astellas, DMK, Erytech, Inveric, Pahxiam, Pherecydes, Point, TFF, Tonix, Ubsher-Smith.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akero, Aslan, Gilead, Hifibio, Intercept, Sagimet, Sumitomo.

Biopharmas raising money in public or private financings, including: Acer, Actimed, Diamedica, Orchard, Oric.

New hires and promotions in the biopharma industry, including: ABVC, Kallyope, Uniqure.

The top 10 biopharma stock gainers and losers for the week.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alzamend, Aptorum, Biocity, Compugen, Horizon, Hyloris, Ideaya, Inhibikase, Inmed, Invivyd, Jasper, Madrigal, Memo, Palleon, Reviva, Roivant, Seelos, Sellas, Tvardi, Vaxxinity.

Year-to-date money raised in public, private and other financings of biopharma companies.